Meta description: This report covers an Ankara University led study that tests an EEG derived pain index to detect nociceptive events during procedural sedation and monitored anesthesia care. Publication date context: February 19, 2026.
This regulatory update describes a trial designed to evaluate an EEG derived pain index as a monitor for nociception in procedural sedation. The conditions in the source text include Monitoring Noxious Events Using EEG Derived Pain Indices; Procedural Sedation and Analgesia; Monitored Anesthesia Care. The sponsor is Ankara University and the recruitment status is Recruiting as of 2026-02-19. The emphasis is on whether EEG derived pain index signals align with nociceptive events during sedation to support analgesia titration and patient safety in Monitored Anesthesia Care. The available record does not report results yet.
What changed in nociception monitoring during procedural sedation?
The project described centers on a trial framework that seeks to monitor nociceptive events using an EEG derived pain index during procedural sedation and analgesia with Monitored Anesthesia Care. The sponsor is Ankara University and the recruitment status is indicated as Recruiting on the ClinicalTrials.gov entry referenced in the source text. The study aims to determine whether an EEG derived pain index can provide an objective signal that complements clinical observations and motor responses to noxious stimuli during procedures. This aligns with broader efforts to enhance patient safety and analgesia management in sedated patients using objective nociception monitoring tools.
Scope of the study
The available summary outlines a single trial focus in a sedation environment with a defined set of conditions. While no numerical performance metrics are disclosed in the source, the involvement of a university sponsor signals a formal research activity with regulatory implications for future use as a monitoring aid.
Who is affected and why this matters?
Clinicians performing procedural sedation, anesthesiology teams, quality and risk managers, and device sponsors should monitor this work. If the EEG derived pain index proves to provide timely nociception signals, it may influence analgesia titration and patient safety practices during Monitored Anesthesia Care. Regulators will review the evidence when considering the safety and performance expectations for such a monitoring aid.
Key stakeholders
Stakeholders include practitioners in sedation settings, institutional review groups, and sponsor organizations. The interplay between EEG based signals and clinical assessment will guide future regulatory discussions on intended use and risk management for these monitoring tools.
What is the role of EEG derived pain indices in Monitored Anesthesia Care?
The source text notes that the study targets nociceptive event detection through EEG derived pain indices during procedural sedation. The goal is to provide an objective adjunct to clinical evaluation to improve safety and analgesia control. No efficacy results are reported in the summary, and device level claims remain subject to regulatory review once data are available.
Intended use and safety considerations
As described, the approach is a monitoring aid intended to indicate nociception during sedation. Any regulatory evaluation will focus on intended use, performance interpretation, and safety profile consistent with regulatory guidance for monitoring devices.
What are regulatory implications for new nociception monitoring tools?
The presentation of this trial underlines ongoing regulatory interest in objective nociception monitoring during sedation. Stakeholders should follow updates on the ClinicalTrials.gov entry and await future data on device performance and safety. The sponsor, Ankara University, and the recruitment status signal potential pathways for future submissions or regulatory alignments depending on trial outcomes.
External link to the official trial record: ClinicalTrials.gov record NCT07413848.
- 1. What is being studied A EEG derived pain index to detect nociception during procedural sedation and Monitored Anesthesia Care.
- 2. Who sponsors Ankara University is listed as sponsor.
- 3. What is the recruitment status It is Recruiting as of February 19 2026.
In summary, the trial represents an effort to validate an EEG derived pain index as a nociception monitoring tool in sedation contexts. The presence of a sponsor and recruitment status signals regulatory interest and potential future reporting on device performance and safety. Stakeholders should monitor the trial updates and ensure any use of such indices follows evidence based practice.
Disclaimer This article is intended for clinical quality and regulatory professionals. It is not legal advice and should not be considered regulatory guidance. Always refer to official regulatory documents and guidelines for the jurisdiction involved.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07413848?term=medical+device